Ligand Pharmaceuticals
LGND
#4189
Rank
C$2.96 B
Marketcap
$154.08
Share price
-1.90%
Change (1 day)
55.72%
Change (1 year)

EPS for Ligand Pharmaceuticals (LGND)

EPS in 2023 (TTM): $2.11

According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is $2.25. In 2022 the company made an earnings per share (EPS) of -$2.83 a decrease over its 2021 EPS that were of $4.95.

EPS history for Ligand Pharmaceuticals from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.11-174.6%
2022-$2.83-157.23%
2021$4.95-2571.43%
2020-$0.20-100.46%
2019$43.82353.48%
2018$9.661025%
2017$0.86-700%
2016-$0.14-100.87%
2015$16.551859.32%
2014$0.845.36%
2013$0.808.0704505322479E+18%
2012$0.0000000000-100%
2011$0.70-194.23%
2010-$0.74548.38%
2009-$0.11-98.7%
2008-$8.85-136.52%
2007$24.22-787.8%
2006-$3.52-14.58%
2005-$4.12-21.31%
2004-$5.24-55.15%
2003-$11.6881.33%
2002-$6.442.74%
2001-$6.27-45.93%
2000-$11.60-14.56%
1999-$13.57-45.52%
1998-$24.91-3.97%
1997-$25.94132.31%
1996-$11.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$20.26 801.27%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.52-122.93%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.01 122.98%๐Ÿ‡ฌ๐Ÿ‡ง UK
$2.61 16.03%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.66 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.77 245.81%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.68 152.87%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.33 226.11%๐Ÿ‡บ๐Ÿ‡ธ USA
$20.17 797.15%๐Ÿ‡บ๐Ÿ‡ธ USA